• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Northpond Ventures: Investment Portfolio & Startup News

Northpond Ventures

To add a bio or update investment portfolio click update information.

Investment Portfolio

    OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platformOMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
    OMass Therapeutics
    15 Oct 2026

    OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform

    OMass Therapeutics is a biotechnology company developing small molecule therapeutics against highly validated target ecosystems in endocrinology and immunology. OMass Therapeutics develops OMS1620 for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome and advances an SLC15A4 inhibitor for lupus and related diseases.

    Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapiesMestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies
    Mestag Therapeutics
    16 Mar 2026

    Mestag Therapeutics secures £30m to advance fibroblast immunology cancer therapies

    Mestag Therapeutics develops antibody treatments based on fibroblast immunology for cancer and inflammatory diseases. It is building therapies designed to direct and drive immune responses using fibroblast-immune biology.

Northpond Ventures
    • Life Sciences
  • 2(12 months)
  • npv.vc

More venture news

  • Isomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI
    Isomorphic Labs
    17 Nov 2026

    Isomorphic Labs unlocks a £3.8bn Series C round led by Greenoaks and Sequoia Capital to design new medicines with AI

    Series CLife Sciences
  • Fractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on
    Fractile
    11 Nov 2026

    Fractile raises a £540m Series C from investors including Thrive and Founders Fund to build the chips that AI frontiers run on

    Series CDeep Tech
  • OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform
    OMass Therapeutics
    15 Oct 2026

    OMass Therapeutics raises a £230m Series C round from VCs including Bain Capital to develop small molecule therapeutics with drug discovery platform

    Series CLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn